Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2552295 | Life Sciences | 2010 | 7 Pages |
Abstract
These results demonstrate that in streptozotocin-induced diabetic rats as well as in normal rats glimepiride and glibenclamide have no beneficial effects on circulating PON1 and PAF-AH activities, but both drugs increase PON1 activity in the liver.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Grażyna Wójcicka, Anna Jamroz-WiÅniewska, Andrzej Marciniak, Ewelina Åowicka, Jerzy BeÅtowski,